Both in Surgical Instruments
Embecta vs Orchestra BioMed Holdings
Over the past year EMBC returned −50.7% and OBIO returned +53.9%; their daily moves had a correlation of 0.10.
EMBC −50.7% OBIO +53.9%Growth of $1, one year, split-adjusted
| Metric | EMBC | OBIO |
|---|---|---|
| Price | $6.62 | $6.08 |
| Market cap | $374.8M | $365.4M |
| Today | +8.80% | +9.35% |
| 1 month | +11.2% | +4.1% |
| 6 months | +85.8% | +47.9% |
| Year to date | −44.3% | +46.5% |
| 1 year | −50.7% | +53.9% |
| Revenue growth (YoY) | −8.1% | −89.5% |
| Gross margin | 56.4% | 71.6% |
| Net margin | 7.8% | −27362.5% |
| P/E (TTM) | 4.3× | — |
| Price / sales | 0.4× | 11.4× |
| Net cash | -$1.27B | $75.1M |
| Dividend yield | 0.60% | — |
| Volatility (60d) | 53.8% | 65.5% |
| Short % of float | 10.5% | 8.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).